Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02083718
What this trial is testing

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Who this might be right for
Stem Cell Transplantation, HematopoieticPoor Graft FunctionHematological Diseases
Nanfang Hospital, Southern Medical University 120
Testing effectiveness (Phase 2)Study completedNCT00795886
What this trial is testing

Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
University of Utah 63
Early research (Phase 1)UnknownNCT06164288
What this trial is testing

Safety and Efficacy Study of hAESCs Therapy for aGVHD

Who this might be right for
GVHD,Acute
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China 18
Testing effectiveness (Phase 2)UnknownNCT02124174
What this trial is testing

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Who this might be right for
Acute Myelogenous Leukemia AMLMyelodysplastic Syndrome MDS
Patrick Stiff 50
Testing effectiveness (Phase 2)Looking for participantsNCT05531786
What this trial is testing

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Graft vs Host Disease
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Early research (Phase 1)Study completedNCT01390311
What this trial is testing

Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Washington University School of Medicine 14
Early research (Phase 1)Looking for participantsNCT07104799
What this trial is testing

Momelotinib During and After HCT in Myelofibrosis

Who this might be right for
MyelofibrosisHematopoietic Cell Transplantation (HCT)
Massachusetts General Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT01434472
What this trial is testing

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Post-Transplant Lymphoproliferative DisorderRecurrent Adult Diffuse Large Cell LymphomaRecurrent B-Cell Non-Hodgkin Lymphoma+4 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT01398501
What this trial is testing

Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital 22
Not applicableStudy completedNCT02032381
What this trial is testing

Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.

Who this might be right for
Bone Marrow Transplant InfectionBronchiolitis ObliteransChronic Respiratory Insufficiency+2 more
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Ended earlyNCT00020722
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT02799147
What this trial is testing

GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid LeukemiaMixed-Lineage Acute Leukemias
St. Petersburg State Pavlov Medical University 27
Not applicableLooking for participantsNCT07693881
What this trial is testing

Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
EBV Infection After Allogenic HSCT
Nanfang Hospital, Southern Medical University 106
Early research (Phase 1)Looking for participantsNCT03326921
What this trial is testing

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Who this might be right for
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more
Fred Hutchinson Cancer Center 24
Early research (Phase 1)Study completedNCT03755414
What this trial is testing

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more
Washington University School of Medicine 55
Very early researchStudy completedNCT04628338
What this trial is testing

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesMyeloid LeukemiaAllogeneic Stem Cell Transplantation
Sawa Ito, MD 8
Not applicableStudy completedNCT00352209
What this trial is testing

Cardiomyopathy Following Stem Cell Transplantation

Who this might be right for
Cardiomyopathy
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Not applicableLooking for participantsNCT03094026
What this trial is testing

Cognitive Training Intervention and Attitudes Towards Genetics

Who this might be right for
Cognitive ImpairmentHematologic NeoplasmsHematopoietic Cell Transplant
University of Alabama at Birmingham 60
Next Page